Channels of the major intrinsic protein (MIP) of the lens transport water, thus playing an important role in lens fiber cell homeostasis. Calmodulin (CAM) interacts with MIP and possibly regulates MIP channel permeability. Protein glycation has been implicated in lens opacification. We previously identified sites of glycation of MIP, which are in close proximity to the putative CAM binding site. This study is aimed to show the effect of in vitro and in vivo glycation on CAM binding to MIP. Our results show that MIP and MP20 are the major CAM binding proteins of the lens membrane. In vitro incubation of lens membranes with 1 M glucose decreased CAM binding by 38% (P 6 0.001). Similarly, there was a progressive decrease in CAM binding to diabetic lens membranes compared to age-matched controls (up to 30% decrease, P 6 0.01). Mutation of K228 and K238 as well as a triple K mutation (K228N, K238N, K259N ) of MIP resulted in a decrease in CAM binding. Thus, post-translational protein modifications of MIP influence CAM binding. Since CAM is the ubiquitous Ca 2 receptor, decreases in CAM binding to the target protein will affect the Ca 2 -mediated cellular processes leading to lens opacification in diabetic and aging lenses. ß
Introduction
Major intrinsic protein (MIP), also known as aquaporin 0 (AQP0), is expressed exclusively in lens ¢ber cells, constituting about 60% of the total membrane proteins [1] . Although the structure is not yet determined, MIP has six membrane-spanning domains, with both amino and carboxy termini located in the cytoplasm [2] . Several immunochemical and ultrastructural studies showed that MIP is organized in tetrameric arrays located in specialized 11^13 nm junctional domains, which, in fact, cover a large portion of the ¢ber cell surface [3] . MIP is the founding member of the growing MIP family of water channel proteins, which are involved in the transport of water and glycerol [4^8] . Mutations in MIP have been identi¢ed in Lop, Cat Fr and H¢ congenital cataract mouse models [9^11] . In these mice, expression of MIP is very low and the C-terminus is truncated, suggesting that normal levels of MIP with an intact C-terminus are essential for the maintenance of lens clarity. Furthermore, MIP is the candidate gene in familial autosomal dominant cataracts [12] , and missense mutations in MIP were identi¢ed in polymorphic and lamellar cataracts [13] .
Calmodulin (CAM), the ubiquitous intracellular Ca 2 receptor, modulates Ca 2 -regulated processes in the cell. In the lens, CAM was shown to be involved in a variety of functions, including activation of cAMP phosphodiesterase and regulation of adenylate cyclase [14] , regulation of Ca 2 -ATPase [15] , modulation of ¢ber cell gap junctions [16] , and passive permeability [17] . CAM was shown to interact with MIP [18, 19] and modulate channel uncoupling in reconstituted liposomes [16] . A putative CAM binding site has been identi¢ed on the C-terminus arm of MIP (residues 223^235) [20] . Recently, Cahalan and Hall [21] demonstrated that a Ca 2 -mediated increase in water permeability of MIP is modulated by CAM. Thus, CAM seems to have a regulatory role in the function of MIP.
Glycation, a post-translational protein modi¢ca-tion, is involved in a variety of age-and diabetesrelated complications, including cataracts. Our earlier studies have shown that MIP undergoes glycation, which a¡ected CAM-mediated channel uncoupling in reconstituted liposomes [22, 23] . Furthermore, we identi¢ed K228, K238, and K259 as the in vitro sites of glycation [24] . CAM also undergoes glycation, and in vitro glycation of CAM resulted in a 54% decrease in its ability to bind Ca 2 [25] . It has been shown that in diabetic rats, lens CAM is glycated resulting in reduced activation of phosphodiesterase [26] . This study has three aims: ¢rst, to show the e¡ect of glycation of MIP on CAM binding; second, to show the e¡ect of in vitro glycation of CAM on this binding; and ¢-nally, to con¢rm the role of lysine residues of MIP in CAM binding. Some of the results here were previously presented in abstract form [27] .
Materials and methods

Lenses
Calf eyes were obtained from a local abattoir, lenses were enucleated, and membranes were prepared as described below. One month old male Sprague-Dawley rats were made diabetic with a single i.v. injection of streptozotocin (55^65 mg/kg body weight). A total of 100 rats were made diabetic and another 30 animals served as controls. About 30^35 diabetic rats were killed 30, 60, and 90 days post streptozotocin injection. On the 90th day, 30 agematched control rats were also killed. About 10^12 pairs of diabetic or control lenses were pooled and membranes were prepared as described below.
Preparation of lens membranes
Calf or rat lens membranes were prepared as per the method of Russell et al. [28] . Decapsulated lenses were homogenized in ice-cold bu¡er A (5 mM TrisHCl, pH 8.5, 1 mM EDTA and 0.1 mM PMSF). The soluble fraction was removed by centrifugation and the pellet was successively washed with 7 M urea, 0.1 M NaOH containing 10 mM L-mercaptoethanol, and bu¡er A, followed by sucrose gradient ultracentrifugation (65%, 45%, 25% and 8% sucrose gradient) at 105 000Ug using an SW55 rotor. Membranes sedimented at the 25^45% interface were collected and washed with sterile PBS.
In vitro glycation of lens membranes
Calf lens membranes were incubated with 1 M glucose in the presence of 0.12 M NaCNBH 3 , at 37³C for 5 days. Following the incubation, the membranes were washed with PBS and used for further studies.
Estimation of levels of glycation
Level of glycation (Amadori products) was estimated by phenyl boronate a¤nity chromatography [23] . Lens membranes were ¢rst solubilized in 1% octyl glucoside and then applied to the column. Protein content in the unbound and bound fractions was estimated and the level of glycation was expressed as a percentage.
Site-directed mutagenesis
In order to generate lysine mutants, the sequences coding for K228, K238 and K259 were mutated to N by a single base change using a PCR based site-directed mutagenesis protocol (QuickChange kit, Stratagene). This protocol allows speci¢c mutations in any double stranded plasmid. The MIP/pBlueBacIII construct was used as the template with oligonucleotide primers, as follows.
The K238N mutant was generated using: 5P-CTC TTC CCT CGG CTC AAC AGT GTT TCT GAG AGAC-3P (sense); 5P-GTC TCT CAG AAA CAC TGT TGA GCC GAG GGAAG-3P (antisense). The K238N mutant was generated using: 5P-CTG TCT ATT CTC AAC GGT TCC AGG-3P (sense); 5P-CTG GGC CTG GAA CCG TTG AGA ATAG-3P (antisense). The K259N mutant was generated using: 5P-GGA ACC TGT TGA ACT GAA CAC CCA GGC CCTG-3P (sense); 5P-CAG GGC CTG GGT GTT CAG TTC AAC AGG TTCC-3P (antisense). The triple K mutant (K228N, K238N, K259N) was generated by sequentially mutating each lysine residue.
Baculovirus expression of wild type and lysine mutant MIP
The wild type and mutant MIP were expressed in the baculovirus expression system as described earlier [29] . Brie£y, the cDNA coding for wild type and lysine mutant MIP were directionally cloned into the pBlueBacIII shuttle vector and transferred to AcMNPV baculovirus genome by homologous recombination. The resultant AcMNPV/MIP recombinant was used to transfect sf9 insect cells.
The sf9 cells expressing MIP (wild type and lysine mutant) were settled by gentle centrifugation at 500 rpm for 10 min. The cells were washed twice with Tris-NaCl bu¡er (50 mM Tris, pH 8.4 containing 0.15 M NaCl, 1 mM KCl, 1 mM CaCl 2 , and 0.5 mM MgCl 2 ), resuspended in bu¡er A (5 mM Tris, pH 8.5, 1 mM EDTA, and 0.1 mM PMSF) and lysed by sonication (probe type sonicator, 15 s burstsU4). The lysate was centrifuged at 20 000Ug for 15 min. Pelleted cell membranes were washed extensively with bu¡er A and used in the calmodulin binding studies as described elsewhere.
In vitro glycation of calmodulin
About 100 Wg of a¤nity puri¢ed bovine brain CAM (Calbiochem, La Jolla, CA) was incubated with 0.35 M glucose at 37³C for 5 days [25] . The incubation medium also contained 1 mM CaCl 2 , 0.1% sodium azide, and PBS in a ¢nal volume of 0.4 ml. After the incubation, 5 ml of cold PBS was added and the mixture was concentrated to 0.5 ml in microconcentrators (3 kDa cuto¡, Amicon). The glycated CAM was then iodinated with 125 I as described below.
Iodination of calmodulin
CAM was iodinated with
125 I (Amersham Radiochemicals) by the lactoperoxidase method [30] . Iodinated CAM was separated on a Sephadex G-25 column (Pharmacia Biotech) and used in direct binding and gel overlay assays.
Calmodulin binding assay
Direct binding of CAM to the lens membranes was done according to the procedure described by Graf et al. [30] . Brie£y, the assay mixture contained 1 mg of bovine serum albumin (BSA), 6 mM MgCl 2 , 0.8 mM CaCl 2 , 100 mM NaCl, 20 mM KCl, 0.5 mM EGTA, 25 mM Tris-HCl bu¡er, pH 7.4, and 0.5 mg lens membranes. To this mixture, 125 I-CAM was added and incubated for 30 min at 37³C. Binding was stopped by the addition of ice-cold Tris-HCl bu¡er and centrifuged in a microfuge at 15 000Ug for 20 min at 4³C. The pellet was washed three times and resuspended in Tris-HCl bu¡er and an aliquot was counted in a Q counter.
A binding curve was generated with normal calf lens membranes and di¡erent amounts (5^250 ng) of 125 I-CAM. Competitive binding assays were done identically with variable amounts (0^100 ng) of unlabeled calmodulin and a constant amount (125 ng) of 125 I-CAM.
Gel overlay assay
CAM binding to MIP was determined by the gel overlay assay described by Louis et al. [18, 19] . Brie£y, lens membranes or sf9 cell membranes (expressing wild type or lysine mutant MIP) were fractionated on 12% SDS-PAGE (0.75 mm thick), ¢xed for 3 h (three changes) in 25% isopropanol and 10% acetic acid mixture, washed for 1 h (three changes) in gel overlay bu¡er (50 mM Tris-HCl, pH 7.6, 0.2 M NaCl, and 1 mM CaCl 2 ), blocked with 1% BSA for 2 h, and incubated overnight with 125 I-CAM (approx. 3U10 6 cpm) in gel overlay bu¡er. Gels were then washed thoroughly for 3 h in gel overlay bu¡er, dried, and processed for autoradiography.
Results
In vitro and in vivo glycation of lens membrane proteins
The level of glycation (Amadori products) was estimated by phenyl boronate a¤nity chromatography. In vitro incubation of bovine lens membranes with 1 M glucose for 5 days resulted in a 5-fold increase of early glycation compared to control incubations (P 6 0.001) (Fig. 1A) . There was a gradual increase in the level of glycation of diabetic rat lens membranes, reaching an about 2-fold higher level on the 90th day post streptozotocin injection compared to non-diabetic controls. These increases were statistically signi¢cant (P 6 0.05 on the 30th day and P 6 0.001 on the 60th and 90th days, when compared with non-diabetic controls) (Fig. 1B) .
Binding of 125 I-calmodulin to lens membranes
In order to show the speci¢city of 125 I-CAM binding to lens membranes, concentration and competitive inhibition curves were generated with normal calf lens membranes. We observed a concentration dependent increase in the binding of 125 I-CAM to lens membranes (Fig. 2A) . When increasing amounts of unlabeled CAM was added as a competitor a linear decrease of 125 I-CAM binding was seen (Fig. 2B ). There was a 60% decrease in the radioactivity incorporation when 100 ng of unlabeled CAM was used as the competitor for 125 ng of 125 I-CAM (Fig.  2B) .
In order to show the e¡ect of in vitro glycation, bovine lens membranes incubated with and without glucose were used in the binding assays. There was a 38% (P 6 0.01) decrease in 125 I-CAM binding to the in vitro glycated calf lens membranes compared to K228N, K238N, K259N , and the triple K mutant, were expressed in the baculovirus expression system and then used in CAM binding studies. *P 6 0.05; **P 6 0.01 compared to respective controls or wild type. control incubations (Fig. 3A) . Similarly, there was a progressive decrease in the binding of calmodulin to diabetic rat lens membranes. The decrease was about 11%, 23% and 30% on day 30, 60 and 90 diabetic rats, respectively, when compared to non-diabetic controls (Fig. 3B) .
To identify the CAM binding proteins in lens membranes, control and 90th day diabetic rat lens membrane proteins were resolved on SDS-PAGE and the gel overlay assay was performed. As expected, we found that in diabetic lenses, MIP is partially cleaved to 24 kDa and 22 kDa proteins (Fig.  4A) . Possibly MP20 also degraded to lower molecular mass products (not resolved on the gel). In agreement with earlier reports [18, 19] , our gel overlay assay shows that MIP and MP20 are the major CAM binding proteins in lens membranes (Fig. 4B ). As expected, there was a signi¢cant decrease in CAM binding to MIP in 90th day diabetic lenses compared to controls (compare lane 2 with lane 1, Fig. 4B ). No binding to MP20 was observed in diabetic lenses (compare lane 2 to 1, Fig. 4B ). Interestingly, CAM did not bind to the degradation products of MIP (24 kDa or 22 kDa peptides) either in control or diabetic lenses (Fig. 4B) .
Studies with lysine mutant MIP
Since lysine residues are the major glycation sites, each of the three lysine residues were replaced with asparagine residues by site-directed mutagenesis. The resultant K228N, K238N, K259N, and triple K mutant (K228N, K238N, and K259N) were expressed in the baculovirus expression system and the e¡ect of these lysine mutations on CAM binding was studied. For direct binding assay, the insect cell membranes expressing either wild type MIP or lysine mutant MIP were used. As shown in Fig. 3C, K228N,  K238N and triple lysine mutations resulted in a signi¢cant decrease in CAM binding compared to wild type (P 6 0.01). However, the K259N mutation seems to have no e¡ect on CAM binding. Furthermore, the e¡ect of lysine mutations on CAM binding was also analyzed by the gel overlay assay (Fig. 5) . Wild type and mutant MIP were ¢rst puri¢ed by gel permeation HPLC as described earlier [29] and then subjected to the gel overlay assay to measure CAM binding. The intensity of the stained gels and corresponding autoradiograms were determined by densitometry. The ratio obtained for wild type was taken as 100% and compared with di¡erent mutants. The ratios for lysine mutations were 89 þ 5% for K228N, 86 þ 11% for K238N, 103 þ 7% for K259N and 51 þ 6% for triple lysine mutant. In agreement with the direct binding assay, the gel overlay assay also showed a 49% decrease in CAM binding to the triple lysine mutant (Fig. 5B, lane 5 ). K228N and K238N lysine mutations showed some decrease in CAM binding, and K259N had no e¡ect on CAM binding (Fig. 5B) . CAM was glycated in vitro, iodinated, and used in the gel overlay assay. Lens membranes from control (lane 1) and 90th day diabetic (lane 2) lenses were used in this assay. Note that glycated CAM failed to bind to MIP obtained either from control or diabetic lenses.
E¡ect of glycation of calmodulin on the binding
Since CAM itself is also a target for glycation [25] , CAM was ¢rst glycated in vitro, iodinated, and used in the gel overlay assay. While non-glycated CAM readily bound to MIP and MP20 (see Fig. 4 ), the glycated CAM failed to bind to normal or diabetic rat lens membranes (Fig. 6B) .
Discussion
This study shows that CAM binding to MIP is decreased in diabetic lenses. Glycation and glycation-induced protein conformational changes seem to play an important role in the interaction of CAM with the binding site on MIP. These results also demonstrate that lysine residues at the putative CAM binding site on MIP play an important role in this binding. Since CAM is a ubiquitous Ca 2 binding protein, decreased CAM binding to MIP is likely to a¡ect Ca 2 -mediated cellular processes, including water permeability, and thus a¡ecting lens ¢ber cell homeostasis.
MIP is the major CAM binding protein in lens ¢ber cell membranes. Earlier studies have shown CAM-mediated channel uncoupling in reconstituted liposomes [16] . Glycation of MIP resulted in only partial uncoupling by CAM [22] . As shown in Fig.  3A , in vitro glycation decreased CAM binding to MIP. Thus it appears that the partial uncoupling seen in our earlier studies [22] may in fact be due to decreased binding of CAM to glycated MIP.
How does glycation in£uence CAM binding? The putative CAM binding site on MIP has been identi¢ed as residues 223^235 [20] , and Lys228 and Lys238 are two of the ¢ve basic residues at this binding site. Earlier, we identi¢ed Lys228, Lys238, and Lys259 as the in vitro glycation sites in MIP [23] . It is expected that glycation of Lys228 and Lys238 would decrease the net positive charge at the CAM binding domain, which would a¡ect the binding. Additionally, protein conformational changes brought about by glycation may also in£uence CAM binding. To understand the role of lysine residues in CAM binding we carried out binding studies using lysine mutant MIPs. As shown in Fig. 3C , there was an about 30^40% decrease in CAM binding to K228N, K238N and triple lysine mutants compared to wild type. As expected, the K259N mutation seems to have no e¡ect on CAM binding (Fig. 3C) . It is expected that deletion of three positively charged residues would bring about not only signi¢cant charge di¡erences but also dramatic conformational changes compared to the deletion of single positively charged residues. Although the gel overlay assay con¢rmed a signi¢-cant decrease in CAM binding to the triple lysine mutant (Fig. 5B, lane 5) , single lysine mutations showed only a marginal change in CAM binding. Thus it appears that there are some di¡erences in accessibility of the binding site to CAM. In the direct binding assay, the MIP is embedded in the lipid bilayer possibly in tetrameric con¢guration, whereas in the gel overlay assay the proteins are dissociated from their membrane components making the accessibility of the binding site relatively easier. Taken together these analyses show that lysine residues, particularly at the binding site, play an important role in the binding of CAM to MIP.
In diabetic lenses, we observed a progressive increase in MIP glycation (Fig. 1B) along with a parallel decrease in CAM binding (Figs. 2B and 4) , which con¢rms our in vitro results. The gel overlay assay showed degradation of MIP to 22 kDa and 24 kDa products in diabetic lenses, and CAM did not bind to these degraded products (Fig. 4) , suggesting that intact MIP is needed for CAM binding. Our recent mass spectrometric analysis showed that K238 is one of the major truncation sites in the diabetic lenses (unpublished observations). Based on these observations, it is concluded that charge di¡erences and/or protein conformational changes and truncation in£uence CAM binding to MIP.
Earlier studies showed that CAM is also the target of glycation, which a¡ects Ca 2 binding [25] . In addition, it was shown that CAM is glycated in diabetic rat lenses [26] . The data presented in Fig. 6 show that in vitro glycated CAM bound neither to normal MIP from controls rats nor to the glycated MIP from diabetic rats. It is interesting to note that there was only a 40% decrease in CAM binding when MIP is glycated, whereas glycation of CAM resulted in 100% loss of binding. The rate of glycation of membrane integral proteins, like MIP, could be far lower than that of soluble cytosolic proteins such as CAM. We estimated the level of glycation by phenyl boro-nate a¤nity chromatography, and glycation of CAM was 4-fold higher than that of MIP under the experimental conditions used in this study (data not shown). Furthermore, the e¡ect of glycation on these proteins seems to be di¡erent. Glycation of CAM signi¢cantly reduces its Ca 2 binding capacity and possibly Ca 2 -mediated conformational changes are needed for the binding to the target site. This may explain the di¡erential response of these two proteins as a result of glycation. Furthermore, it is expected that glycation of CAM and glycation of the CAM binding site on MIP will have a synergistic e¡ect on the CAM-MIP interaction.
In the avascular lens, MIP channels provide the network of channels for the passage of nutrients and antioxidants and the removal of metabolic waste products. Recent studies have unequivocally demonstrated that MIP channels transport water and glycerol [5^8], thus playing an important role in lens ¢ber cell homeostasis. Cahalan and Hall [21] have elegantly demonstrated the regulation of MIP water permeability by Ca 2 , which is modulated by CAM. However, there are di¡erences between their study and ours. Using an oocyte expression system, Cahalan and Hall [21] showed that CAM inhibitors increased MIP water permeability by 3.7-fold, thus shifting from a low to high permeability mode of MIP water permeability. However, our results show a decreased binding of CAM to MIP in diabetic lenses (Figs. 3 and 4) , which is associated with decreased water permeability [31] . These apparent differences may be explained by the fact that our studies used normal MIP under pathological conditions (diabetes), whereas Cahalan and Hall [21] used a heterologous expression system under in vitro conditions.
In conclusion, this study shows that post-translational protein modi¢cations in£uence CAM binding to the MIP target protein, a¡ecting Ca 2 -mediated cellular processes. Since MIP is involved in water transport of the lens, decreased CAM binding may a¡ect the CAM-mediated modulation of MIP channels, resulting in lens opaci¢cation.
